Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Accumulated Expenses (2018 - 2019)

Neurogene's Other Accumulated Expenses history spans 2 years, with the latest figure at $339000.0 for Q4 2019.

  • For Q4 2019, Other Accumulated Expenses rose 41.25% year-over-year to $339000.0; the TTM value through Dec 2019 reached $339000.0, up 41.25%, while the annual FY2019 figure was $339000.0, 41.25% up from the prior year.
  • Other Accumulated Expenses reached $339000.0 in Q4 2019 per NGNE's latest filing, up from $240000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $339000.0 in Q4 2019 to a low of $240000.0 in Q4 2018.